Skip to main content

Press

Interview with CEO Peter Wolpert

Link to video »
  • All pressreleases
  • Regulatory
2019-02-13 | Press release
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
2019-02-12 | Press release
Moberg Pharma AB Year-end report 2018
2019-02-12 | Press release
Moberg Pharma divests its OTC-business for USD 155 million and secures new funding for MOB-015 in transformational transaction

Read more »

2019-02-13 | Press release
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)
2019-02-12 | Press release
Moberg Pharma AB Year-end report 2018
2019-02-12 | Press release
Moberg Pharma divests its OTC-business for USD 155 million and secures new funding for MOB-015 in transformational transaction

Read more press releases »

Latest report

2019-02-12 Moberg Pharma AB Year-end report 2018

Kontaktperson press och media:

Peter Wolpert, VD
Tel: +46 8 522 307 08
Email: peter.wolpert@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2019-05-14 Interim report for January - March 2019

IMAGE BANK  »